- Home
- BW vs TVGN Comparison
BW vs TVGN Comparison
Compare BW & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BW | TVGN |
|---|---|---|
| Founded | 1867 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 544.4M | 89.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BW | TVGN |
|---|---|---|
| Price | $5.34 | $0.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.50 | $5.00 |
| AVG Volume (30 Days) | ★ 2.9M | 1.4M |
| Earning Date | 11-04-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $721,285,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 80.30 | N/A |
| 52 Week Low | $0.22 | $0.36 |
| 52 Week High | $7.77 | $1.92 |
Technical Indicators
Market Signals| Indicator | BW | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 43.20 |
| Support Level | $4.73 | $0.37 |
| Resistance Level | $5.10 | $0.40 |
| Average True Range (ATR) | 0.55 | 0.03 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 35.45 | 32.47 |
Price Performance
Historical ComparisonAbout BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.